Assessment of the percutaneous penetration of cisplatin: The effect of monoolein and the drug skin penetration pathway

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 73, Issue 1, 2009, Pages 90-94

  Simonetti, Leonardo D D ^a   Gelfuso, Guilherme M ^a   Barbosa, Julie C R ^a   Lopez, Renata F V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Barrier function; Cisplatin; Monoolein; Skin penetration; Stratum corneum

Indexed keywords

CISPLATIN; GLYCEROL OLEATE; PROPYLENE GLYCOL;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG STRUCTURE; EAR; IN VITRO STUDY; NONHUMAN; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SKIN PENETRATION; STRATUM CORNEUM; SWINE;

ADMINISTRATION, CUTANEOUS; ANIMALS; CISPLATIN; DRUG SYNERGISM; GLYCERIDES; PERMEABILITY; SIGNAL TRANSDUCTION; SKIN; SKIN ABSORPTION; SWINE;

EID: 68349127374     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2009.04.016     Document Type: Article

References (44)

1. Na R., Stender I.M., and Wulf H.C. Can autofluorescence demarcate basal cell carcinoma from normal skin? A comparison with protoporphyrin IX fluorescence. Acta Derm. Venereol. 81 (2001) 246-249
2. Wagnieres G., Hadjur C., Grosjean P., Braichotte D., Savary J.F., Monnier P., and Van den Bergh H. Clinical evaluation of the cutaneous phototoxicity of 5,10,15,20-tetra(m-hydroxyphenyl)chlorine. Photochem. Photobiol. 68 (1998) 382-387
3. De Rosa F.S., and Bentley M.V.L.B. Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives. Pharm. Res. 17 (2000) 1447-1455
4. Luxenberg M.N., and Guthrei T.H. Chemotherapy of basal cell and squamous cell carcinoma of the eyelids and periorbital tissues. Ophthamology 93 (1986) 504-510
5. Peng Q., Warloe T., Moan J., Heyerdahl H., Steen H.B., Nesland J.M., and Giercksky K.E. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem. Photobiol. 62 (1995) 906-913
6. Szeimies R.M., Karrer S., Sauerwald A., and Landthaler M. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology 192 (1996) 246-251
7. Zeitouni N.C., Shieh S., and Oseroff A.R. Laser and photodynamic therapy in the management of cutaneous malignancies. Clin. Dermatol. 19 (2001) 328-339
8. Lopez R.F.V., Bentley M.V.L.B., Delgado-Charro M.B., Salomon D., Van den Bergh H., Lange N., and Guy R.H. Enhanced delivery of 5-aminolevulinic acid esters by iontophoresis in vitro. Photochem. Photobiol. 77 (2003) 304-308
9. Lopez R.F.V., Lange N., Guy R.H., and Bentley M.V.L.B. Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters. Adv. Drug Deliv. Rev. 56 (2004) 77-94
10. Guthrie Jr. T.H., and Porubsky E.S. Successful systemic chemotherapy of advanced squamous cell carcinoma of the skin with cis-diamminedichloroplatinum III and doxorubicin. Laryngoscope 92 (1982) 1298-1299
11. Wieman T.J., Shively E.H., and Woodcock T.M. Responsiveness of metastatic basal-cell carcinoma to chemotherapy: a case report. Cancer 52 (1983) 1583-1585
12. Guthrie Jr. T.H., Porubsky E.S., Mcelveen L.J., and Harmon J.D. Cisplatin and doxorubicin, an effective chemotherapy combination in the treatment of advanced basal cell and squamous carcinoma of the skin. Cancer 55 (1985) 1629-1632
13. Chang B.K., Guthrie T.H., Hayakawa K., and Gangarosa L.P. A pilot study of iontophoretic cisplatin chemotherapy of basal and squamous cell carcinomas of the skin. Arch. Dermatol. 129 (1993) 425-427
14. El-Kahteeb M., Appleton T.G., Charles B.G., and Gahan L.R. Development of HPLC conditions for valid determinations of hydrolysis products of cisplatin. J. Pharm. Sci. 88 (1999) 319-326
15. Raaf J.H., Krown S.E., Pinsky C.M., Cunningham-Rundles W., Safai B., and Oettgen H.F. Treatment of Bowen's disease with topical dinitrochlorobebzene and 5-flourouracil. Cancer 37 (1976) 1633-1642
16. Strange P.R., and Lang Jr. P.G. Long-term management of basal cell nervus syndrome with topical tretinoin and 5-fluorouracil. J. Amer. Acad. Dermatol. 27 (1992) 845
17. Brenner S., Wolf R., and Dascalu D.I. Topical tretinoin treatment in basal cell carcinoma. J. Derm. Surg. Oncol. 19 (1993) 264-266
18. Mir L.M., Glass L.F., Sersa G., Teissie J., Domenge C., Miklavcic D., Jaroszeski M.J., Orlowski S., Reintgen D.S., Rudolf Z., Belehradek M., Gilbert R., Rols M.P., Belehradek Jr. J., Bachaud J.M., DeConti R., Stabuc B., Cemazar M., Coninx P., and Heller R. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br. J. Cancer 77 (1988) 2336-2342
19. Sersa G., Stabuc B., Cemazar M., Jancar B., Miklavcic D., and Rudolf Z. Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. Eur. J. Cancer 34 (1988) 1213-1218
20. Gibbs P., Gonzalez R., Lee L.A., and Walsh P. Medical management of cutaneous malignancies. Clin. Dermatol. 19 (2001) 298-304
21. Hostynek J.J., Hinz R.S., Lorence C., and Guy R.H. Human skin penetration by metal compounds. In: Roberts M.R., and Walters K.A. (Eds). Dermal Absorption and Toxicity Assessment (2007), CRS Press, New York 647-668
22. Patton J.S., and Carey M.C. Watching fat digestion. Science 204 (1979) 145-148
23. Ogiso T., Iwaki M., and Paku T. Effects of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors. J. Pharm. Sci. 84 (1995) 482-488
24. Pereira G.R., Collett J.H., Garcia S.B., Thomazini J.A., and Bentley M.L.V.B. Glycerol monooleate/solvents systems for progesterone transdermal delivery: in vitro permeation and microscopic studies. Braz. J. Pharm. Sci. 38 (2002) 55-62
25. Williams A.C., and Barry B.W. Penetration enhancers. Adv. Drug Deliv. Rev. 56 (2004) 603-618
26. Lopes L.B., Collett J.H., and Bentley M.V.L.B. Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer. Eur. J. Pharm. Biopharm. 60 (2005) 25-30
27. Smith E.W., and Maibach W.I. Percutaneous Penetration Enhancers. second ed. (1995), CRC Press, New York
28. Andrews P.A., Wung W.E., and Howell S.B. A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate. Anal. Biochem. 143 (1984) 46-56
29. Herai H., Gratieri T., Thomazine J.A., Bentley M.V.L.B., and Lopez R.F.V. Doxorubicin skin penetration from monoolein-containing propylene glycol formulations. Int. J. Pharm. 329 (2007) 88-93
30. Larrucea E., Arellano A., Santoyo S., and Ygartu P. Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxican and its retention in the skin. Eur. J. Pharm. Biopharm. 52 (2001) 113-119
31. Aboofazeli R., Zia H., and Needham T.E. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement. Drug Deliv. 9 (2002) 239-247
32. Kim C.K., Kim J.J., Chi S.C., and Shim C.K. Effect of acid and urea on the penetration of ketoprofen through rat skin. Int. J. Pharm. 99 (1993) 109-118
33. Clancy M.J., Corish J., and Corrigan O.I. A comparison of the effects of electrical current and penetration enhancers on the properties of human skin using spectroscopic (FTIR) and calorimetric (DSC) methods. Int. J. Pharm. 105 (1994) 47-56
34. Naik A., Pechtold L.A.R.M., Potts R.O., and Guy R.H. Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans. J. Contr. Release 37 (1995) 299-306
35. Bhatia K.S., and Singh J. Synergistic effect of iontophoresis and a series of fatty acids on LHRH permeability through porcine skin. Int. Pharm. Sci. 87 (1997) 81-89
36. R. Steluti, F.S. De Rosa, J.H. Collet, M.V.L.B. Bentley, Influence of monoolein on in vivo protoporphyrin IX accumulation in hairless mouse skin induced by 5-aminolevulinic acid, in: Proceedings of VI Pharmatech III Annual Meeting of the SBTF, vol. 6, 2001, pp. 161-162.
37. Pellett M.A., Hadgraft J., and Roberts M.S. The back diffusion of glucose across human skin in vitro. Int. J. Pharm. 193 (1999) 27-35
38. Sekkat N., Naik A., Kalia Y.N., Glikfeld P., and Guy R.H. Reverse iontophoretic monitoring in premature neonates: feasibility and potential. J. Contr. Release 81 (2002) 83-89
39. Dash A.K., Gong Z., Miller D.W., Huai-Yan H., and Laforet J.P. Development of a rectal nicotine delivery system for the treatment of ulcerative colitis. Int. J. Pharm. 190 (1999) 21-34
40. Knorr F., Lademann J., Patzelt A., Sterry W., Blume-Peytavi U., and Vogt A. Follicular transport route-research progress and future perspectives. Eur. J. Pharm. Biopharm. 71 (2008) 173-180
41. Patzelt A., Richter H., Buettemeyer R., Roewert Huber H.J., Blume-Peytavi U., Sterry W., and Lademann J. Differential stripping demonstrates a significant reduction of the hair follicle reservoir in vitro compared to in vivo. Eur. J. Pharm. Biopharm. 70 (2008) 234-238
42. Tanojo H., Hostynek J.J., Mountford H., and Maibach H.I. In vitro permeation of nickel salts through human stratum corneum. Acta Derm. Venereol. Suppl. 212 (2001) 19-26
43. 4). J. Pharm. Sci. 97 (2008) 4249-4257
44. Lademann J., Richter H., Teichmann A., Otberg N., Blume-Peytavi U., Luengo J., Weiß B., Schäfer U.F., Lehr C.M., Wepf R., and Sterry W. Nanoparticles - an efficient carrier for drug delivery into the hair follicles. Eur. J. Pharm. Biopharm. 66 (2007) 159-164